Hint mode is switched on Switch off
For swift navigation between sections

Highland Therapeutics

Organization name
Highland Therapeutics Inc.
Country name
Canada
Country of registration
-
Industry
Chemical and Petrochemical Industry
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds
  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Highland Therapeutics Inc. is a Toronto-based pharmaceutical company. The company is engaged in the development and commercialization of novel drugs utilizing the DELEXIS, which is drug delivery technology platform developed by Ironshore Pharmaceuticals & Development, Inc., a wholly owned subsidiary of Highland Therapeutics Inc.

Awards

Documentation

Stocks

Public debt by currencies

Codes

  • CIK
    0001449225
Registration is required to get access.